SynthesisInternational journal of molecular sciences2022

Comparative Efficacy and Safety of P2Y12 Inhibitor Monotherapy and Dual Antiplatelet Therapy in Patients with and without Diabetes Mellitus Undergoing Percutaneous Coronary Intervention.

Wen-Han Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.